We read the results of the CRITICS study by Annemieke Cats and colleagues1 with great interest. This study was, to the best of our knowledge, the first trial to directly compare postoperative chemoradiotherapy with perioperative chemotherapy in patients with resectable gastric adenocarcinoma. Despite the negative results, some aspects of the study warrant closer attention.
https://ift.tt/2MyPSLb
Παρασκευή 29 Ιουνίου 2018
[Correspondence] Adjuvant therapy in resectable gastric cancer—the CRITICS trial
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου